title: Cushing's syndrome and severe adrenal suppression in patients treated with ritonavir and inhaled nasal fluticasone.
authors.forename: F
authors.initials: F
authors.lastname: Chen
authors.forename: T
authors.initials: T
authors.lastname: Kearney
authors.forename: S
authors.initials: S
authors.lastname: Robinson
authors.forename: P T
authors.initials: PT
authors.lastname: Daley-Yates
authors.forename: S
authors.initials: S
authors.lastname: Waldron
authors.forename: D R
authors.initials: DR
authors.lastname: Churchill
mesh_terms: D000280:Administration, Inhalation; D000328:Adult; D000730:Androstadienes / Q000009:adverse effects* / Q000627:therapeutic use; D003480:Cushing Syndrome / Q000139:chemically induced*; D065607:Cytochrome P-450 Enzyme Inhibitors; D003864:Depression, Chemical; D004359:Drug Therapy, Combination; D000068298:Fluticasone; D005938:Glucocorticoids / Q000009:adverse effects* / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D008297:Male; D019438:Ritonavir / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000730:Androstadienes; D065607:Cytochrome P-450 Enzyme Inhibitors; D005938:Glucocorticoids; D000068298:Fluticasone; D019438:Ritonavir